Gastric cancer screening using the serum pepsinogen test method

Gastric Cancer

Volumn 9, Issue 4, 2006, Pages 245-253

  Miki, Kazumasa ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Cancer screening; Gastric cancer; Helicobacter pylori antibody; High risk group; Serum pepsinogen

Indexed keywords

BACTERIUM ANTIBODY; PEPSINOGEN; PEPSINOGEN I; PEPSINOGEN II;

ANTIBODY TITER; ATROPHIC GASTRITIS; CANCER DIAGNOSIS; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; GASTROSCOPY; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; JAPAN; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARD; STOMACH CANCER; SYSTEMATIC REVIEW;

FALSE POSITIVE REACTIONS; HUMANS; MASS SCREENING; PEPSINOGEN A; PEPSINOGEN C; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 33751558093     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-006-0397-0     Document Type: Review

References (96)

1. SC Huang K Miki J Sano M Ichinose N Kawamura H Oka 1988 Pepsinogens I and II in gastric cancer: An immunohistochemical study using monoclonal antibodies Jpn J Cancer Res 79 1139 46
2. A Oshima N Hirata T Ubukata K Umeda I Fujimoto 1986 Evaluation of a mass screening program for stomach cancer with a case-control study design Int J Cancer 38 829 33
3. A Fukao Y Tsubono I Tsuji S Hisamichi N Sugahara A Takano 1995 The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan: a population-based case-control study Int J Cancer 60 45 8
4. K Miki M Ichinose A Shimizu SC Huang H Oka C Furihata 1987 Serum pepsinogens as a screening test of extensive chronic gastritis Gastroenterol Jpn 22 133 41
5. K Miki M Ichinose KB Ishikawa N Yahagi M Matsushima N Kakei 1993 Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer Jpn J Cancer Res 84 1086 90
6. M Ichinose N Yahagi M Oka H Ikeda K Miki M Omata 2001 Screening for gastric cancer in Japan GY Wu K Aziz Cancer screening. A practical guide for physicians Humana Press Potawa 87 102
7. K Miki M Morita M Sasajima R Hoshina E Kanda Y Urita 2003 Usefulness of gastric cancer screening using the serum pepsinogen test method Am J Gastroenterol 98 735 9
8. T Shiga M Nishizawa G Hayashi 1998 Comparison between the serum pepsinogen test method and the conventional photofluorography. A randomized controlled study K Miki Pepsinogen test method Igaku-shoin Tokyo 56 62 in Japanese
9. K Miki M Ichinose N Kakei N Yahagi M Matsushima S Tsukada 1995 The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer K Takahashi Aspartic proteinases: structure, function, biology and biomedical implications Plenum Press New York 139 43
10. S Kikuchi O Wada K Miki T Nakajima T Nishi O Kobayashi 1994 Serum pepsinogen as a new marker for gastric carcinoma among young adults Cancer 73 2695 702
11. F Kitahara K Kobayashi T Sato Y Kojima T Araki MA Fujino 1999 Accuracy of screening for gastric cancer using serum pepsinogen concentrations Gut 44 693 7
12. K Miki M Ichinose N Yahagi T Suzuki M Oka Y Shimizu 1997 Efficiency of gastric cancer screening system using serum pepsinogen test JR Siewert JD Roder Progress in gastric cancer research 1997 Monduzzi Editore Bologna 87 93
13. H Ohata M Oka K Yanaoka Y Shimizu C Mukoubayashi K Mugitani 2005 Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography Cancer Sci 96 713 20
14. IM Samloff 1971 Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence Gastroenterology 61 185 8
15. IM Samloff WM Liebman 1973 Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence Gastroenterology 65 36 42
16. K Miki 2000 Pepsinogen K Miki Gastric malignant tumor Medical View Tokyo 78 84 in Japanese
17. GN Stemmermann IM Samloff A Nomura JH Walsh 1980 Serum pepsinogen I and gastrin in relation to extent and location of intestinal metaplasia in the surgically resected stomach Dig Dis Sci 25 680 7
18. K Miki M Ichinose N Kawamura M Matsushima HB Ahmad M Kimura 1989 The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects Jpn J Cancer Res 80 111 4
19. A Kodoi M Yoshihara K Sumii K Haruma G Kajiyama 1995 Serum pepsinogen in screening for gastric cancer J Gastroenterol 30 452 60
20. P Lauren 1965 The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma Acta Path Microbiol Scand 64 31 49
21. P Correa 1992 Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention Cancer Res 52 6735 40
22. A Fukao S Hisamichi N Ohsato N Fujino N Endo M Iha 1993 Correlation between the prevalence of gastritis and gastric cancer in Japan Cancer Causes Control 4 17 20
23. M Kabuto H Imai S Tsugane S Watanabe 1993 Correlation between atrophic gastritis prevalence and gastric cancer mortality among middle-aged men in 5 areas in Japan J Epidemiol 3 35 9
24. T Namekata K Miki M Kimmey T Fritsche D Hughes D Moore 2000 Chronic atrophic gastritis and Helicobacter pylori infection among Japanese Americans in Seattle Am J Epidemiol 151 820 30
25. AMY Nomura GN Stemmermann IM Samloff 1980 Serum pepsinogen I as a predictor of stomach cancer Ann Intern Med 93 537 40
26. MT Fahey GS Hamada IN Nishimoto LP Kowalski K Lriya JJ Gama-Podrigues 2000 Ethnic differences in serum pepsinogen levels among Japanese and non-Japanese Brazilian gastric cancer patients and controls Cancer Detect Prev 24 564 71
27. D Palli A Decarli F Cipriani D Forman D Amadori C Avellini 1993 Plasma pepsinogens, nutrients and diet in areas of Italy at varying gastric cancer risk Cancer Epidem Biomar Prev 1 45 50
28. J Parsonnet IM Samloff LM Nelson N Orenreich JH Vogelman GD Freidman 1993 Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma Cancer Epidem Biomar Prev 2 461 6
29. GN Stemmermann IM Samloff AMY Nomura LK Heilburn 1987 Serum pepsinogens I and II and stomach cancer Clin Chim Acta 163 191 8
30. K Matsusako M Itoh K Yokochi T Miyamoto T Joh T Takeuchi 1987 An enzyme immunoassay for pepsinogen II: chronological changes in serum pepsinogen II concentrations Clin Chim Acta 169 239 47
31. M Ito K Haruma S Kaya T Kamada S Kim A Sasaki 2002 Serological comparison of serum pepsinogen and anti-parietal cell antibody levels between Japanese and German patients Eur J Gastroenterol Hepatol 14 123 7
32. IM Samloff K Varis T Ihamaki M Siurala JI Rotter 1982 Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia Gastroenterology 82 204 9
33. A Tamm K Villako M Harkonen SL Karonen 1984 Serum pepsinogen I and the state of gastric mucosa in an Estonian population sample Scand J Gastroenterol 19 1091 4
34. C Ley A Mohar J Guarner R Herrera-Goepfert LS Figueroa D Halperin 2001 Screening markers for chronic atrophic gastritis in Chiapas Mexico Cancer Epidem Biomar Prev 10 107 12
35. A Aromaa TU Kosunen P Knekt J Maatela L Teppo OP Heinonen 1996 Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer Am J Epidemiol 144 142 9
36. M Asaka T Kimura M Kudo H Takeda S Mitani T Miyazaki 1992 Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population Gastroenterology 102 760 6
37. PM Webb KJ Hengels H Moller DG Newell D Palli JB Elder 1994 The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group Gastroenterology 107 1335 44
38. S Yoshida D Saito 1996 Gastric premalignancy and cancer screening in high-risk patients Am J Gastroenterol 91 839 43
39. M Dinis-Ribeiro G Yamaki K Miki A Costa-Pereira M Matsukawa M Kurihara 2004 Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis J Med Screen 11 141 7
40. M Ichinose K Miki C Furihata T Kageyama R Hayashi H Niwa 1982 Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders Clin Chim Acta 126 183 91
41. IM Samloff 1982 Pepsinogens I and II: Purification from gastric mucosa and radioimmunoassay in serum Gastroenterology 82 26 33
42. SC Huang K Miki C Furihata M Ichinose A Shimizu H Oka 1988 Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies with data on peptic ulcer and gastric cancer Clin Chim Acta 175 37 50
43. N Konishi K Matsumoto Y Hiasa Y Kitahori I Hayashi H Matsuda 1995 Tissue and serum pepsinogen I and II in gastric cancer identified using immunohistochemistry and rapid ELISA J Clin Pathol 48 364 7
44. Y Hattori H Tashiro T Kawamoto Y Kodama 1995 Sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens Jpn J Cancer Res 86 1210 5
45. K Miki 2001 Pepsinogen handbook Medical View Tokyo Includes 17 papers in Japanese
46. K Bodger JI Wyatt RV Heatley 1999 Serological screening before endoscopy: The value of Helicobacter pylori serology, serum recognition of the CagA and VacA proteins, and pepsinogen I Scand J Gastroenterol 34 856 63
47. FY Chang KH Lai TF Wang SD Lee YT Tsai SH Tsay 1992 Location and type of gastric carcinoma in relation to pepsinogen I level in blood Scand J Gastroenterol 27 884 8
48. L Zhang WJ Blot WC You YS Chang RW Kneller ML Jin 1996 Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population Cancer Epid Biomar Prev 5 627 30
49. T Knight J Wyatt A Wilson S Greaves D Newell K Hengels 1996 Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high-risk groups Br J Cancer 73 819 24
50. M Inoue S Kobayashi A Matsuura N Hamajima K Tajima S Tominaga 1998 Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis Cancer Epidem Biomar Prev 7 261 3
51. F Sitas R Smallwood D Jewell PR Millard DG Newell SG Meuwissen 1993 Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological makers of chronic atrophic gastritis Cancer Epidem Biomar Prev 2 119 23
52. A Oksanen P Sipponen A Miettinen S Sarna H Rautelin 2000 Evaluation of blood tests to predict normal gastric mucosa Scand J Gastroenterol 35 791 5
53. M Kekki IM Samloff K Varis T Ihamäki 1991 Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis Scand J Gastroenterol 186 109 16
54. K Varis M Kekki M Harkonen P Sipponen IM Samloff 1991 Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer Scand J Gastroenterol 186 117 23
55. E Mardh S Mardh B Mardh K Borch 2002 Diagnosis of gastritis by means of a combination of serological analyses Clin Chim Acta 320 17 27
56. K Miki M Ichinose 1989 Serum pepsinogen I level in patients with stomach cancer: its value and limitation in clinical use Gan To Kagaku Ryoho 16 1122 8 in Japanese
57. H Fukunaga K Morita N Otsuka R Morita 1989 Fundamental and clinical study for pepsinogen I and II RIABEAD Kit Igaku-To-Yakugaku (J Med Pharm Sci) 21 905 14 in Japanese
58. K Miki 1992 Mass screening of stomach neoplasms by serum pepsinogen analysis Nippon Naika Gakkai Zasshi 81 654 9 in Japanese
59. Y Kimura T Fujii K Hamamoto N Miyagawa K Tsuda S Tanada 1999 Evaluation of serum pepsinogen I and II of patients with gastric cancer Kaku Igaku 26 1127 33 in Japanese
60. G Yamaki Y Shiga R Nagahama T Nakashima K Nomoto H Nakaya 2001 Pepsinogen test Stomach and Intestine 36 1591 7 in Japanese with English abstract
61. M Dinis-Ribeiro A Costa-Pereira C Lopes J Barbosa M Guilherme L Moreira-Dias 2002 Is pepsinogen test valid for the diagnosis of gastric dysplasia and adenocarcinoma? Gut 51 Suppl. III A185
62. WC You WJ Blot L Zhang RW Kneller JY Li ML Lin 1993 Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer Cancer Epidem Biomar Prev 2 113 7
63. S Kikuchi Y Inaba O Wada K Miki H Tenjin E Kaneko 1995 The association of smoking and drinking habits with serum pepsinogens Int J Epidemiol 24 346 53
64. S Wagner K Haruma U Gladziwa B Soudah M Gebel J Bleck 1994 Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: Significance of inflammation and effect of bacterial eradication Am J Gastroenterol 89 1211 8
65. A Ogihara S Kikuchi A Hasegawa M Kurosawa K Miki 2000 Relationship between Helicobacter pylori infection and smoking and drinking habits J Gastroenterol Hepatol 15 271 6
66. FM Hunter P Correa E Fontham B Ruiz M Sobhan IM Samloff 1993 Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis Dig Dis Sci 38 2081 6
67. G Biasco GM Paganelli D Vaira J Holton Febo GDi S Brillanti 1993 Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pylori in dyspeptic patients J Clin Pathol 46 826 8
68. PM Webb JE Crabtree D Forman The Eurogast Study Group 1999 Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: An international study Gastroenterology 116 269 76
69. RJ Schlemper SD van der Werf JP Vandenbroucke I Biemond CB Lamers 1995 Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori Gut 37 199 204
70. JG Goedhard I Biemond JP Gilliams G Pals J Kreuning 1985 Serum pepsinogen I levels: assessment of gastric acid secretion? Pepsinogens in man: clinical and genetic advances Prog Clin Biol Res 173 139 46
71. I Kato K Miki N Muñoz JH Vivas G Lopez S Peraza 1995 Determinants of plasma pepsinogen levels in population at high risk for stomach cancer in Venezuela Int J Cancer 62 512 8
72. M Yoshihara K Sumii K Haruma K Kiyohira N Hattori Y Kitadai 1998 Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects Am J Gastroenterol 93 1090 6
73. K Varis PR Taylor P Sipponen IM Samloff OP Heinonen D Albanes 1998 Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene Scand J Gastroenterol 33 294 300
74. M-S Wu W-C Lee J-T Lin H-P Wang T-H Wang C-J Chen 1995 A novel tree-structured analysis for non-invasive diagnosis of gastric adenocarcinoma Anticancer Res 15 2739 43
75. F Farinati F Di Mario M Plebani R Cielo MC Fanton F Valiante 1991 Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer? Ital J Gastroenterol 223 194 6
76. M Goldschmiedt CC Barnett BE Schwarz WE Karnes JS Redfern M Feldman 1991 Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women Gastroenterology 101 977 90
77. MT Serrono Lanas Al S Lorente R Sainz 1997 Cytokine effects on pepsinogen secretion from human peptic cells Gut 40 42 8
78. S Lorente O Doiz M Trinidad Serrano J Castillo A Lanas 2002 Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells Gut 50 13 8
79. H Fukuda D Saito S Hayashi H Hisai H Ono S Yoshida 1995 Helicobacter pylori infection, serum pepsinogen level and gastric cancer: A case-control study in Japan Jpn J Cancer Res 86 64 71
80. K Varis P Sipponen F Laxén IM Samloff JK Huttunen PR Taylor 2000 Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dyplasia Scand J Gastroenterol 35 950 6
81. S Kikuchi M Kurosawa T Sakiyama H Tenjin K Miki O Wada 2000 Long-term effect of Helicobacter pylori infection on serum pepsinogens Jpn J Cancer Res 91 471 6
82. M Plummer J Vivas JL Fauchere GD Giudice AS Pẽa A Ponzetto 2000 Helicobacter pylori and stomach cancer: A case-control study in Venezuela Cancer Epidem Biomar Prev 9 961 5
83. H Ohata S Kitauchi N Yoshimura K Mugitani M Iwane H Nakamura 2004 Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer Int J Cancer 109 138 43
84. H Watabe T Mitsushima Y Yamaji M Okamoto R Wada T Kokubo 2005 Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study Gut 54 764 8
85. th International Gastric Cancer Congress. Yokohama 2005;145-50
86. M Sasajima R Hoshina K Miki 2002 Annual reports (1997-2000) of the Research Committee for the Study of Gastric Cancer Screening System Using the Serum Pepsinogen Clin Gastroenterol 17 1555 68 in Japanese with English abstract
87. Y Tsubono S Hisamichi 2000 Screening for gastric cancer in Japan Gastric Cancer 3 9 18
88. Miki K. Annual report of the Research Committee of the Study of High Risk Strategy of Gastric Cancer Screening, supported by a Grant-in-Aid for the Research from the Ministry of Health, Labour and Welfare, Japan. Tokyo; 2005(April). p. 1-288 (in Japanese)
89. M Muto Y Saito T Koike K Miki 2000 A case of gastric cancer with high pepsinogen II levels in both serum and ascites Dig Endosc 12 42 5
90. K Ozasa JH Kurata A Higashi K Hayashi H Inokuchi K Miki 1999 Helicobacter pylori infection and atrophic gastritis. A nested case-control study in a rural town in Japan Dig Dis Sci 44 253 6
91. Y Watanabe JH Kurata S Mizuno M Mukai H Inokuchi K Miki 1997 Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan Dig Dis Sci 42 1383 7
92. M Asaka T Kimura M Kato M Kudo K Miki K Ogoshi 1994 Possible role of Helicobacter pylori infection in early gastric cancer development Cancer 73 2691 4
93. Asaka M, Kato M, Kudo M, Katagiri M, Nishikawa K, Yoshida J, et al. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population. Eur J Gastroenterol Hepatol 1995;s7-10
94. AMY Nomura LN Klonel K Miki GN Stemmermann LR Wilkens MT Goodman 2005 Helicobacter pylori, pepsinogen and gastric adenocarcinoma in Hawaii J Infect Dis 191 2075 81
95. K Miki Y Urita AMY Nomura LN Kolonel GN Stemmermann LR Wilkens 2005 The relationship between Helicobacter pylori, pepsinogen, and gastric adenocarcinoma Gut 54 Suppl. VII A 70
96. M Hatakeyama 2004 Oncogenic mechanisms of the Helicobacter pylori CagA protein Nature Rev Cancer 4 688 94